Identification and characterisation of pMOO-32
1 7 3
Following observations of the high prevalence of bla CTX-M-32 , a search for common plasmid 1 7 4 replicon types was conducted which revealed an IncHI2-ST2 replicon in almost all the 1 7 5 sequenced bla CTX-M-32 -positive isolates. It was therefore hypothesised that there was a 1 7 6 dominant plasmid type occurring across the study. To test this hypothesis, transconjugations 1 7 7
were attempted into E. coli DH5α using bla CTX-M-32 -positive farm isolate DK ( Table 4) . One methodologies to sequence the plasmid to closure. pMOO-32 is a 226,022-bp conjugative 1 8 0 plasmid belonging to the ST2-IncHI2 incompatibility group, harbouring repHI2 and repHI2A 1 8 1 replication genes. It contains 245 putative ORFs and has a GC content of 45.5% (Figure 1) . 1 8 2 pMOO-32 encodes the following antimicrobial resistance genes: bla CTX-M-32 , strA, strB, 1 8 3 aph(6)-Ic, aph(3')-IIa and tetB as well as genes encoding resistance to the heavy metal 1 8 4 compound, tellurite (terABCDEFWXYZ) and a HipAB type II toxin-antitoxin system along 1 8 5 with a second partial system (higB toxin gene). bla CTX-M-32 is encoded downstream of an 1 8 6
ISECp1 element within which there is an ISKpn26 insertion encoded in the opposite 1 8 7 orientation (Figure 2) . This same genetic environment was also observed in 4 bla CTX-M-32 -1 8 8 positive but IncHI2 plasmid-negative ST10 isolates collected from 2 farms. There were 2 1 8 9 additional IncHI2 plasmid-negative ST765 isolates, both from the same farm, that encoded 1 9 0 bla CTX-M-32 where the immediate genetic environment differed by a truncation in ISEcp1. 1 9 1 (AMP), CTX, cefepime (FEP), aztreonam (AZT), streptomycin (STR), neomycin (NEO) and 1 9 9 tetracycline (TET). The cattle ST88 and human ST1193 transconjugants were, additional to 2 0 0 their starting wild-type resistance profile, resistant to CTX, FEP and AZT. These results 2 0 1 ( Table 4 ) are indicative of the functionality of the bla CTX-M-32 gene harboured by pMOO-32. The complete nucleotide sequence of pMOO-32 was submitted to GenBank under the 2 0 4 accession number MK169211. Subsequently a multiplex PCR was designed, based on the 2 0 5 pMOO-32 sequence, to screen all group 1 bla CTX-M -positive isolates for the presence of radius of each other, tested positive for the presence of pMOO-32-like plasmids using this 2 0 8 test. WGS performed on 73 isolates from 24 of these farms identified the pMOO-32-like 2 0 9 plasmids in 27 STs, suggesting that its dominance is largely a result of horizontal rather than 2 1 0 clonal transmission. Ten farms harboured pMOO-32-like plasmids in isolates of more than 2 1 1 one ST. The most frequently identified STs were ST69 and ST10, found in 18 isolates from 7 2 1 2 farms, and 6 isolates from 4 farms, respectively. Using the closed sequence of pMOO-32 as 2 1 3 a reference, sequencing reads from all 73 isolates were mapped; this indicated that the 2 1 4 plasmids exhibited 94-100% identity to the reference sequence. The differences between the 2 1 5 reference plasmid, pMOO-32 and the 73 isolates could be attributed to a loss or gain of 2 1 6 mobile genetic elements, but no rearrangements were observed to the plasmid backbone or 2 1 7 changes to resistance gene content. The presence of pMOO-32-like plasmids in 27 STs indicates that plasmid-mediated 2 1 9 transmission plays a significant role in the dissemination of bla in the farms in this 2 2 0 study. The origins and geographical reach of pMOO-32 remain to be established, however it 2 2 1 was shown that none of the 10 farms located in a geographically separated sub-region of 2 2 2 this study area were found to harbour this plasmid, or bla CTX-M-32 , suggesting the plasmid 2 2 3 may be specific to a particular geographic area; further investigations would be necessary to 2 2 4 prove this. The high-level prevalence and stability of pMOO-32-like plasmids could be a consequence 2 2 6 of the HipAB-type II toxin-antitoxin system, making it likely that this plasmid can persist in the 2 2 7 absence of antimicrobial selection pressure. Growth curve assays indicated a 12-40% 2 2 8 fitness cost (reduction in OD 600 ) of pMOO-32 carriage in E. coli DH5α at the start and end of 2 2 9 the exponential growth phase in M9 minimal medium (data not shown). However, despite 2 3 0 this cost in growth terms, pMOO-32 was stably maintained over 10 days of passaging in the 2 3 1 absence of antibiotic pressure in the farm isolates, their respective transconjugants, as well In this study bla CTX-M-32 was clearly shown to be the dominant mechanism of CTX resistance 2 3 9 due to the very high prevalence of pMOO-32-like plasmids across 26 farms. A previous 2 4 0 study where bla CTX-M-32 was first described found that it confers increased hydrolytic activity variants, but this requires further investigation. acquired mechanism of CTX-R identified; bla CMY carriage was evident, but to a much lesser coli isolates, so the possibility exists that pMOO-32-like plasmids will disseminate further, 2 5 3 perhaps into other animal populations and even into humans. Genome sequencing was provided by MicrobesNG (http://www.microbesng.uk), which is supported by the BBSRC (grant number BB/L024209/1). The authors declare no conflict of interests. Farming and veterinary businesses who 2 6 6 contributed data and permitted access for sample collection were not involved in the design 2 6 7 of this study or in data analysis and were not involved in drafting the manuscript for 2 6 8 publication. n  m  e  n  t  /  u  p  l  o  a  d  s  /  s  y  s  t  e  m  /  u  p  l  o  a  d  s  /  a  t  t  a  c  h  m  e  n  t  _  d  a  t  a  /  f  i  l  e  /  2  1  5  1  8  0  /  d  h  _  1  3  2  5  3  2  7  8   4 . Streptomycin and neomycin sensitivities were determined using tobramycin EUCAST interpretation guidelines, and tetracycline according to guidelines for Yersinia enterocolitica. 
